- Home
- Levosimendan Comprehensive patent search
Levosimendan Comprehensive patent search
This market research, not available anymore on the publisher's website, was withdrawn from our database.
To get an alternative report, you can either :
- Have a look at the list of documents hereafter
- Launch a new search below
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
DOWNLOAD THESE REPORTS NOW!
PharmaPoint: Chronic Myeloid Leukemia (CML) - Current and Future Players
- $ 2 995
- Industry report
- by Global Data
- May 2013
- 44 pages
PharmaPoint: Chronic Myeloid Leukemia (CML) - Current and Future Players Summary GlobalData has released its pharma report, ?PharmaPoint: Chronic Myeloid Leukemia (CML) - Current and Future Players?. The report is a vital source of up-to-date information with in-depth analysis on the companies in the ...
Industries: Pathology | Countries: World
Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- by Global Data
- May 2013
- 53 pages
Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022?. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cance ...
Industries: Pathology | Countries: World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Sprycel (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- by Global Data
- May 2013
- 56 pages
Sprycel (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Sprycel (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022?. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cance ...
Industries: Pathology | Countries: Japan, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- by Global Data
- May 2013
- 54 pages
Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022?. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cance ...
Industries: Pathology | Countries: Japan, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Bosulif (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- by Global Data
- May 2013
- 54 pages
Bosulif (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Bosulif (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022?. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cance ...
Industries: Pathology | Countries: World, Europe, United States, Spain, Italy, France, Germany, Japan, United Kingdom
Iclusig (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- by Global Data
- May 2013
- 54 pages
Iclusig (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Iclusig (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022?. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cance ...
Industries: Pathology | Countries: World, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom
Synribo (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
- $ 3 495
- Industry report
- by Global Data
- May 2013
- 50 pages
Synribo (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Synribo (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022?. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cance ...
Industries: Pathology | Countries: World, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022
- $ 3 995
- Industry report
- by Global Data
- May 2013
- 46 pages
EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022 Summary Meningococcal disease is caused by Neisseria meningitidis, which is an encapsulated, Gram-negative bacterium that has an incidence of one to three cases per 100,000 population worldwide (Giuliani et al., 2006). Strains of ...
Industries: Pathology | Countries: World, Australia, Brazil, Spain, United States, United Kingdom, Italy, France, Germany
MediFocus: Medical Devices for the Treatment of Obesity
- $ 3 995
- Industry report
- by Global Data
- May 2013
- 130 pages
MediFocus: Medical Devices for the Treatment of Obesity Summary The obesity treatment market is drastically underserved and considerably underdeveloped. While bariatric surgery has significant improvement in recent decades, evolving to become the gold standard for proven treatment in the absence of ...
Industries: Pathology
Nrt Smoking Cessation Aids Market Overview in Turkey
- $ 898
- Industry report
- by Euromonitor International
- May 2013
- 24 pages
In 2009, NRT smoking cessation aids recorded considerably higher growth than the CAGR achieved over the review period following the smoking ban, which was introduced in July of that year. The implementation of this law and restrictions on smoking encouraged increasing numbers of people to try and give ...
Industries: Tobacco, Pathology | Countries: Turkey
24/7 Customer Service
You can call our customer service 24 hours a day / 7 days a week
- +1 718 618 4302
ref:plp2013
Reportlinker.com © Copyright 2013. All rights reserved.
